New Mexico · Compounded Tirzepatide
Ozari connects New Mexico residents with licensed telehealth clinicians who review medical eligibility online and, when appropriate, prescribe compounded tirzepatide. Plans start at $125/month on the 3-Month Starter Plan for eligible first-time GLP-1 patients, with published tiers and no insurance requirement.
Prescriptions are filled by Ozari's named 503A partners — Hallandale Pharmacy (PCAB-accredited) and VialsRx (USP 797 sterile compounding) — and shipped directly to your New Mexico address.
Compounded semaglutide and tirzepatide are prescribed for documented individual patient need by licensed physicians and prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Start Online Visit
Quick Answer
Compounded tirzepatide is a patient-specific prescription prepared by a licensed U.S. compounding pharmacy; it is not an FDA-approved finished product like branded Zepbound. For New Mexico residents, Ozari's model is fully online: complete a health intake, receive physician review, get a prescription sent to a named 503A pharmacy if clinically appropriate, and receive medication at home with plans from $125/month on the Starter tier.
All plans below are sourced from Ozari's current treatment pricing. No insurance required.
Tap to switch plan type
$375 billed every 3 months
Save $330
Pricing last verified: July 28, 2026
Branded comparison: Retail pharmacy cash pricing for branded Zepbound is typically well above $1,000 per month without savings applied. LillyDirect self-pay listings currently range from about $299 per month at starter dose to $399–$449 per month at higher doses — verify LillyDirect for current terms.
New Mexico has a telehealth parity statute and the New Mexico Medical Board permits physicians to prescribe to patients they've evaluated via synchronous video without a prior in-person visit. The shortage of in-state obesity medicine specialists makes telehealth access through platforms like Ozari disproportionately important for New Mexico patients seeking GLP-1 care.
A physician-led workflow designed for New Mexico patients who want transparent pricing and named pharmacy partners.
Step 1
Answer structured health questions from anywhere in New Mexico. Most patients finish in under 10 minutes.
Step 2
A licensed clinician reviews your history, contraindications, and goals before any prescription is written.
Step 3
If prescribed, your order is prepared by a licensed 503A partner pharmacy and shipped to your New Mexico address with cold-chain packaging when required.
Step 4
Message your care team for titration questions, side effects, and refills instead of navigating clinic phone trees.
Ozari does not sell tirzepatide from inventory. Every order is patient-specific, written by a licensed prescriber, and prepared by either Hallandale Pharmacy — a PCAB-accredited 503A facility in Fort Lauderdale, Florida — or VialsRx, a U.S.-licensed 503A pharmacy compounding under USP 797 standards. Your shipment label identifies the dispensing pharmacy. Ozari Health holds LegitScript certification for its telehealth platform, which third parties can verify independently.
PCAB-accredited 503A compounding pharmacy in Fort Lauderdale, Florida
U.S.-licensed 503A compounding pharmacy operating under USP 797 sterile compounding standards
Local delivery context and pricing for major New Mexico metros.
Common questions from New Mexico patients considering compounded tirzepatide.
Compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual prescription. Branded Zepbound is an FDA-approved finished product with a full FDA review of safety, efficacy, and manufacturing. Compounded versions are not FDA-approved, not generic equivalents, and are prescribed only when a licensed clinician determines they are appropriate for your history.
Ozari publishes flat-rate plans for New Mexico: $125/month equivalent on the 3-Month Starter Plan ($375 every 3 months, first-time GLP-1 users), $199/month on Quarterly ($597 every 3 months), or $235/month month-to-month. Free shipping is included; no insurance is required.
Safety depends on appropriate prescribing, pharmacy standards, and follow-up care — not price alone. Ozari uses named 503A partners (Hallandale Pharmacy, PCAB-accredited; VialsRx, USP 797) and a LegitScript-certified telehealth platform. Compounded products are still not FDA-approved finished drugs, so your clinician must review contraindications before treatment.
You complete a secure online intake, a licensed clinician reviews your record, and a prescription is sent to a 503A partner pharmacy only if treatment is medically appropriate. Medication ships to your New Mexico address. There is no checkout without clinician review.
In SURMOUNT-1 (NEJM 2022), FDA-approved tirzepatide 15 mg with lifestyle support produced a mean 20.9% body weight reduction at 72 weeks versus 3.1% with placebo. Published trial averages are not guarantees for compounded products or for any individual patient.
New Mexico has a telehealth parity statute and the New Mexico Medical Board permits physicians to prescribe to patients they've evaluated via synchronous video without a prior in-person visit. The shortage of in-state obesity medicine specialists makes telehealth access through platforms like Ozari disproportionately important for New Mexico patients seeking GLP-1 care.
Ozari routes prescriptions to Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) or VialsRx (U.S.-licensed 503A, USP 797). Your vial label and patient materials identify the dispensing pharmacy for that shipment.
Yes. Eligible New Mexico patients receive free expedited shipping to residential or business addresses statewide once a prescription is approved and filled. Cold-chain packaging is used when required for medication stability in transit.
Complete your intake online. A licensed clinician reviews your information before any prescription is written.
Start Online Visit